Skip to content

Pancreatitis, Acute

BASICS

  • Definition: Acute inflammation of the pancreas, often with local and systemic complications. Reversible if no necrosis or duct disruption.
  • Key Symptoms: Severe epigastric pain (often radiates to back), nausea, vomiting, ileus.

EPIDEMIOLOGY

  • Incidence: 1–5 per 10,000 (no major age or sex predilection)
  • Prevalence: 19 per 10,000
  • Most common GI diagnosis for inpatient admission

ETIOLOGY & PATHOPHYSIOLOGY

Causes

  • Alcohol (adults 30–50y)
  • Gallstones (esp. older adults, median age 69y)
  • Trauma/surgery, drugs, ERCP, hypertriglyceridemia, hypercalcemia
  • Autoimmune (type I: ↑IgG4; type II: normal IgG4)
  • Infections: mumps, coxsackievirus, CMV, EBV, parasites, SARS-CoV-2
  • Tumors, anatomic abnormalities (pancreas divisum, sphincter of Oddi)
  • Cystic fibrosis and rare hereditary forms (AD)
  • Medications (not exhaustive): ACE inhibitors, ARBs, thiazides, azathioprine, steroids, statins, valproic acid, sulfa drugs

Risk Factors

  • Obesity, diabetes, smoking, diet high in saturated fat/cholesterol
  • Alcohol/tobacco use
  • Hypertriglyceridemia, hypercalcemia
  • Genetic mutations (rare)

Pathophysiology

  • Enzymatic autodigestion, interstitial edema, third spacing, local/systemic inflammation.
  • Complications: necrosis, pseudocyst, duct disruption, pancreatic ascites, vascular injury (splenic vein thrombosis, pseudoaneurysm).

GENERAL PREVENTION

  • Avoid excessive alcohol & tobacco
  • Treat metabolic causes (hypertriglyceridemia, hypercalcemia)
  • Discontinue offending meds
  • Cholecystectomy for symptomatic gallstones
  • Diet: limit saturated fats, red meat, eggs

DIAGNOSIS

History

  • Acute onset β€œboring” epigastric pain (often radiates to back)
  • Nausea/vomiting
  • Alcohol or gallstone history
  • Medication or trauma history

Physical Exam

  • Vitals: tachycardia, hypotension, fever
  • Abdomen: epigastric tenderness, ileus, peritoneal signs
  • Rare: Grey Turner (flank) or Cullen (umbilical) sign (hemorrhagic pancreatitis)

Differential Diagnosis

  • Perforated ulcer, cholecystitis, cholangitis, bowel obstruction, MI, aortic aneurysm, mesenteric ischemia

DIAGNOSTIC TESTS & INTERPRETATION

Labs

  • Lipase >3Γ— ULN (more specific than amylase)
  • Amylase >3Γ— ULN (not specific)
  • ALT >3Γ— ULN β†’ high PPV for gallstone pancreatitis
  • Triglycerides (>1,000 mg/dL if hypertriglyceridemia)
  • Bilirubin (if elevated, consider biliary obstruction)
  • WBC, hematocrit (Hct >44 or rising = poor prognosis)
  • Glucose, calcium (may be ↑ in severe disease)
  • BUN (BISAP score)

Imaging

  • Abdominal US: look for gallstones, bile duct dilation
  • CT abdomen: confirm diagnosis, assess severity/complications (do not use IV contrast in hypovolemia)
  • MRCP: evaluate for ductal disease
  • ERCP: only if evidence of cholangitis or obstruction
  • EUS: for idiopathic or suspected autoimmune

Severity Scores

  • BISAP Score: BUN >25, impaired mental status, SIRS, age >60, pleural effusion (1 point each)
  • Ranson Criteria: less commonly used now

TREATMENT

General Measures

  • Hospitalize most cases; ICU if organ dysfunction
  • Aggressive IV fluids: bolus 10 mL/kg, then 1.5 mL/kg/hr, target UO 0.5–1.0 mL/kg/hr, max ~4L in 24h
  • NPO initially, then advance diet as tolerated once pain/ileus resolve (early oral/soft low-fat diet preferred)
  • Remove inciting meds
  • NG tube if intractable vomiting
  • Monitor renal, calcium, glucose, and volume status

Analgesia

  • Use opioids (avoid meperidine)
  • NSAIDs as adjuncts

Antibiotics

  • Not indicated unless infection (cholangitis, necrosis, or abscess)
  • If infection suspected: empiric imipenem/carbapenem or piperacillin-tazobactam

Nutrition

  • Enteral nutrition if unable to eat after 5–7 days (prefer NJ tube)
  • TPN only if enteral not tolerated (avoid lipids if hypertriglyceridemia)

Procedures/Surgery

  • ERCP if cholangitis/obstruction
  • Cholecystectomy before discharge for gallstone pancreatitis (if no necrosis)
  • Necrosectomy or drainage for infected necrosis
  • Plasma exchange/insulin for severe hypertriglyceridemic pancreatitis

ONGOING CARE & FOLLOW-UP

  • Discharge criteria: pain controlled, tolerating oral intake, no sepsis/organ failure
  • Imaging: repeat if persistent symptoms, initial CT showed necrosis/fluid, or labs remain elevated
  • Monitor for complications: pseudocyst (10%), abscess, splenic vein thrombosis, pseudoaneurysm
  • Enzyme supplementation: for necrosis/ductal loss with steatorrhea
  • Diabetes screening: risk of new diabetes after pancreatitis

PROGNOSIS

  • 85–90% resolve spontaneously, 3–5% overall mortality
  • Necrotizing pancreatitis mortality: up to 17%

CLINICAL PEARLS

  • Gallstones & alcohol are leading causes
  • BISAP score is user-friendly and predicts mortality
  • Early oral feeding is preferred if no severe symptoms
  • Mild cases may progress to severe if fluid resuscitation is inadequate
  • Always review and discontinue possible offending drugs
  • Refer severe/evolving cases to tertiary center

ICD-10 Codes

  • K85.9: Acute pancreatitis, unspecified
  • K85.8: Other acute pancreatitis
  • K85.2: Alcohol-induced acute pancreatitis